Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
9.95
-0.18 (-1.78%)
At close: Apr 28, 2026, 4:00 PM EDT
10.22
+0.27 (2.68%)
After-hours: Apr 28, 2026, 5:31 PM EDT
Biodesix Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Biodesix stock have an average target of 32.5, with a low estimate of 20 and a high estimate of 40. The average target predicts an increase of 226.63% from the current stock price of 9.95.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 17, 2026.
Analyst Ratings
The average analyst rating for Biodesix stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Feb 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +101.01% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $30 → $20 | Strong Buy | Maintains | $30 → $20 | +101.01% | Sep 19, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $60 → $40 | Buy | Maintains | $60 → $40 | +302.01% | May 21, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $60 → $30 | Strong Buy | Maintains | $60 → $30 | +201.51% | May 14, 2025 |
Financial Forecast
Revenue This Year
110.85M
from 88.50M
Increased by 25.26%
Revenue Next Year
132.08M
from 110.85M
Increased by 19.15%
EPS This Year
-3.14
from -4.67
EPS Next Year
-1.98
from -3.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 114.6M | 137.1M | |
| Avg | 110.9M | 132.1M | |
| Low | 105.6M | 125.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 29.4% | 23.7% | |
| Avg | 25.3% | 19.2% | |
| Low | 19.3% | 13.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.64 | -1.46 | |
| Avg | -3.14 | -1.98 | |
| Low | -3.55 | -2.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.